|
Laxman Pai, Opalesque Asia: Altas Partners, a healthcare and life sciences investor, has held the final closing of its third fund, Altas Partners Holdings III, with $4 billion of capital commitments.
The North American private equity investment firm based in Toronto, Canada said in a media release that Fund III closed at its $4 billion target and is one-third larger than Altas' $3 billion predecessor fund.
The Fund will provide the Altas team with capital to continue to pursue its distinctive and patient strategy in the coming years, targeting 5-7 businesses that the team is excited to own and build, it said.
"We are very grateful to our investors for their partnership and confidence in Altas and our team," said Andrew Sheiner, CEO of Altas Partners. "Our firm employs a particularly discerning approach to private equity investing, looking for only 1 or 2 new opportunities each year that fit our framework and where we have high conviction."
Andrew added: "We focus on acquiring wonderful businesses with meaningful growth potential and engaging closely with our management teams as a valued partner. Since inception in 2012, we've acquired ten market-leading businesses, and are poised to complete our eleventh investment in a few months, our first in more than two years, consistent with our selective approach."
"We are fortunate to have earned the support and trust of an exceptional group of global investors," added Aryella Frommer, Partner at Altas. "We loo...................... To view our full article Click here
|